ALEXANDRIA, Va., Aug. 18 -- United States Patent no. 12,708,664, issued on Aug. 18, was assigned to argenx BV (Ghent, Belgium).
"Methods of treating paraproteinemic neuropathy with anti-C2 antibodies" was invented by Christophe Blanchetot (Ghent, Belgium), Kevin Budding (Vleuten, Netherlands), Erik Hack (Diemen, Netherlands), Karen Silence (Ghent, Belgium), Inge Van De Walle (Ghent, Belgium), Ludo Van Der Pol (Amersfoort, Netherlands) and Peter Boross (Utrecht, Netherlands).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a method of treating a paraproteinemic neuropathy in a subject by administering to the subject an antagonist of the complement system. The antagonist inhibits ...